SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: majormember who wrote (2832)7/24/1999 12:46:00 PM
From: dave brown  Read Replies (3) of 4140
 
One thing I don't understand is that the CLINICAL
INVESTIGATORS owning the stock is bad AND upper management of the company not owning the stock is bad. Why isn't it a vote of confidence that the people seeing the results first hand think enough of the process to take ownership in it.

This hole question of the eye correction only lasting 18 months, why wouldn't that be OK as long as it is disclosed to the patient? If the procedure is safe and only takes seconds to do, why not have a reasonable fee and have patients come in every 18 months for a check up and possibly have the procedure redone. Nothing lasts forever. Let SNRS put their SAFE product out in the marketplace and let society decide if clearer vision for 18 months at a time is of any value to them.

The FDA just gave SNRS the OK to work on both eyes at the same time. What's the message, "your process is safe enough to risk the total vision of a patient, which is OK because any screw up will wear off in about a year and a half."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext